scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PNAS..109.3927M |
P356 | DOI | 10.1073/PNAS.1119858109 |
P932 | PMC publication ID | 3309760 |
P698 | PubMed publication ID | 22355108 |
P5875 | ResearchGate publication ID | 221851914 |
P50 | author | Alan E Mast | Q90260520 |
P2093 | author name string | Peter B Johansen | |
Lars C Petersen | |||
Susan A Maroney | |||
Mette B Hermit | |||
Catherine E Bonesho | |||
Josephine P Ferrel | |||
Brian C Cooley | |||
Lone V Nielsen | |||
P2860 | cites work | Structure and biology of tissue factor pathway inhibitor | Q28202845 |
Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma | Q28254514 | ||
In vivo fluorescence imaging of large-vessel thrombosis in mice | Q30500329 | ||
Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor | Q33822980 | ||
Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit | Q33843110 | ||
Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis | Q33895278 | ||
AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER. | Q34257237 | ||
WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. | Q34257361 | ||
Active tissue factor pathway inhibitor is expressed on the surface of coated platelets | Q35642785 | ||
The role of tissue factor pathway inhibitor in a revised coagulation cascade | Q36370143 | ||
Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin deposition | Q36823197 | ||
Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice. | Q37418452 | ||
Alternatively spliced isoforms of tissue factor pathway inhibitor | Q37696775 | ||
Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. | Q40575096 | ||
Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth | Q42700253 | ||
Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. | Q42950062 | ||
Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A | Q45868121 | ||
Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor | Q45868138 | ||
Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor. | Q45871920 | ||
Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A. | Q45872405 | ||
Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A. | Q45876184 | ||
Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas | Q45881092 | ||
Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. | Q52526571 | ||
Thrombin Induces the Redistribution and Acute Release of Tissue Factor Pathway Inhibitor From Specific Granules Within Human Endothelial Cells in Culture | Q53722832 | ||
Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1 | Q57374924 | ||
Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma | Q67866847 | ||
Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor | Q70412786 | ||
Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons | Q73307852 | ||
Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor | Q74192371 | ||
Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors | Q77677300 | ||
Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden | Q78057268 | ||
A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice | Q81144269 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hemophilia | Q134003 |
P304 | page(s) | 3927-3931 | |
P577 | publication date | 2012-02-21 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia | |
P478 | volume | 109 |
Q92020423 | A Molecular Revolution in the Treatment of Hemophilia |
Q35784515 | A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development |
Q35126274 | Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor |
Q57289034 | Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia |
Q64113389 | Assessing Blood Clotting and Coagulation Factors in Mice |
Q33585249 | Biology of tissue factor pathway inhibitor. |
Q34657739 | Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets |
Q37268966 | Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor |
Q36852177 | Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ |
Q55447752 | Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S. |
Q92218948 | Defective fibrin deposition and thrombus stability in Bambi-/- mice are mediated by elevated anticoagulant function |
Q39952594 | Development of a tail vein transection bleeding model in fully anaesthetized haemophilia A mice - characterization of two novel FVIII molecules. |
Q55123953 | Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia. |
Q45863501 | Engineering a new generation of hemostatic agents: highlights of the Scientific Session on Hemostasis at the 2013 meeting of the American Society of Hematology |
Q38114123 | Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding severity and prophylaxis |
Q55346403 | Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab. |
Q61796552 | Maintaining extraembryonic expression allows generation of mice with severe tissue factor pathway inhibitor deficiency |
Q90683939 | Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia |
Q26865048 | New insights into the biology of tissue factor pathway inhibitor |
Q38604626 | New products for the treatment of haemophilia |
Q38293116 | Novel therapeutic approaches for haemophilia |
Q36269547 | Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use. |
Q36169665 | Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI. |
Q37007335 | Platelets: Context-Dependent Vascular Protectors or Mediators of Disease |
Q33648222 | Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor |
Q47900623 | Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex |
Q93192263 | Serum lipoprotein(a) and risk of hemorrhagic stroke among incident peritoneal dialysis patients: a large study from a single center in China |
Q93206771 | Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A |
Q37108074 | Targeting TFPI for hemophilia treatment |
Q47215919 | Targeting anticoagulant protein S to improve hemostasis in hemophilia. |
Q55211396 | The Potential Close Future of Hemophilia Treatment - Gene Therapy, TFPI Inhibition, Antithrombin Silencing, and Mimicking Factor VIII with an Engineered Antibody. |
Q38840382 | The hemostatic role of factor XI. |
Q36403196 | Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein |
Q37276726 | Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation |
Q33706688 | Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated region. |
Search more.